Transdermal penetration enhancers: applications, limitations, and potential.

[1]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[2]  T. Nagai,et al.  Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. , 1990, Drug design and delivery.

[3]  J. Hadgraft,et al.  Topical Application of Penetration Enhancers to the Skin of Nude Mice: a Histopathological Study , 1989, The Journal of pharmacy and pharmacology.

[4]  R. Stoughton,et al.  INFLUENCE OF DIMETHYLSULFOXIDE (DMSO) ON HUMAN PERCUTANEOUS ABSORPTION. , 1964, Archives of dermatology.

[5]  R H Guy,et al.  Iontophoresis—Recent Developments * , 1998, The Journal of pharmacy and pharmacology.

[6]  Jonathan Hadgraft,et al.  Transdermal drug delivery: A perspective , 1987 .

[7]  R. Juang,et al.  Ethanol: water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. , 1989, Journal of pharmaceutical sciences.

[8]  Howard I. Maibach,et al.  Evaluation of the Barrier Function of Skin Using Transepidermal Water Loss (TEWL): A Critical Overview , 2014 .

[9]  R. Payne.  Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain. , 1998, Seminars in oncology.

[10]  R. Daynes,et al.  Skin immunology: The Achilles heel to transdermal drug delivery☆ , 1987 .

[11]  D. Crook,et al.  The metabolic consequences of treating postmenopausal women with non‐oral hormone replacement therapy , 1997, British journal of obstetrics and gynaecology.

[12]  S. Mitragotri,et al.  A mechanistic study of ultrasonically-enhanced transdermal drug delivery. , 1995, Journal of pharmaceutical sciences.

[13]  D. Schmitt,et al.  Contact allergens and sodium lauryl sulphate upregulate vascular endothelial growth factor in normal keratinocytes , 1997, The British journal of dermatology.

[14]  Brian W. Barry,et al.  Variations in permeability of human skin within and between specimens , 1984 .

[15]  R. Stoughton.  Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. , 1982, Archives of dermatology.

[16]  W. O. McClure,et al.  Azone®: A New Non-Toxic Enhancer of Cu'Taneous Penetration , 1983 .

[17]  B. W. Barry.  Vehicle Effect: What Is an Enhancer? , 1993 .

[18]  R. Scheuplein,et al.  Permeability of the Skin , 1971 .

[19]  J. Hadgraft,et al.  Pharmaceutical skin penetration enhancement , 1993 .

[20]  R. Guy,et al.  Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. , 1996, Journal of pharmaceutical sciences.

[21]  R. Scheuplein,et al.  Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids. , 1974, The Journal of investigative dermatology.

[22]  T. Higuchi,et al.  Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles. , 1969, Journal of Pharmacy and Science.

[23]  H. Maibach,et al.  Adverse dermatologic reactions to transdermal drug delivery systems. , 1990, Journal of the American Academy of Dermatology.

[24]  W. Jordan,et al.  Comparison of the skin irritation potential of two testosterone transdermal systems: an investigational system and a marketed product. , 1998, Clinical therapeutics.

[25]  H. Maibach,et al.  Epidermal enzymes as penetration enhancers in transdermal drug delivery? , 1996, Journal of pharmaceutical sciences.

[26]  T. Redelmeier,et al.  Skin Barrier: Principles of Percutaneous Absorption , 1996 .

[27]  P. Paronen,et al.  Enhanced delivery of 5-fluorouracil through shed snake skin by two new transdermal penetration enhancers , 1993 .

[28]  T. Morgan,et al.  Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol. , 1998, Journal of pharmaceutical sciences.

[29]  K. Sugibayashi,et al.  Analysis of skin penetration enhancing effect of drugs by ethanol-water mixed systems with hydrodynamic pore theory , 1996 .

[30]  T. Morgan,et al.  Enhanced transdermal delivery of sex hormones in swine with a novel topical aerosol. , 1998, Journal of pharmaceutical sciences.

[31]  I. Sugimoto,et al.  Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats. , 1987, Journal of pharmacobio-dynamics.

[32]  K. Tolman,et al.  Enhanced transdermal delivery of testosterone : a new physiological approach for androgen replacement in hypogonadal men , 1992 .

[33]  G. Flynn,et al.  Percutaneous drug penetration: Choosing candidates for transdermal development , 1988 .

[34]  M. Hashida,et al.  Structure-activity relationship of 1-alkyl- or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers. , 1988, Journal of pharmaceutical sciences.

[35]  J. Hadgraft,et al.  Supersaturated solutions as topical drug delivery systems , 1993 .

[36]  R. Baker,et al.  Transdermal enhancer patent literature , 1993 .

[37]  Weaver,et al.  Theory of electrical creation of aqueous pathways across skin transport barriers. , 1999, Advanced drug delivery reviews.

[38]  D. Jorkasky,et al.  Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapy. , 1998, Clinical therapeutics.

[39]  T. Morgan,et al.  Enhanced skin permeation of sex hormones with novel topical spray vehicles. , 1998, Journal of pharmaceutical sciences.

[40]  H. Maibach,et al.  Sunscreen intolerance. Contact sensitization, photocontact sensitization, and irritancy of sunscreen agents. , 1995, Dermatologic clinics.

[41]  Barry.  Reflections on transdermal drug delivery. , 1999, Pharmaceutical science & technology today.

[42]  W. Olszewski,et al.  Immune cell traffic from blood through the normal human skin to lymphatics. , 1995, Clinics in dermatology.

[43]  V. Papademetriou,et al.  Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension. , 1991, The American journal of medicine.

[44]  Brian W. Barry,et al.  Dermatological Formulations: Percutaneous Absorption , 1983 .